RxDoctor Payments Data

Kevin Hagan

Acute Care · Abington, PANPI 1659347896

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 88.9% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $8,362 and has fallen 74.3% since, to $2,147 in 2025. Among acute care clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,657in general payments, 2019–2025

Across 194 payments — averaging $85.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$15K
  • Boston Scientific$343
  • Abiomed$204
  • Merck$173
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$154
  • Lexicon Pharmaceuticals, Inc.$129
  • plus $838 from 14 others

What the payments were for

  • Consulting fees$8,92454%
  • Travel & lodging$2,51615%
  • Food & beverage$5,21731%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,657 in reported general payments places this provider in the 95th percentile of 872 acute care providers in Pennsylvania.

See all acute care providers in Pennsylvania

Other acute care in Abington

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →